InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Intellia Therapeutics, Inc.

NTLA Clue Score53
United States Fiscal year ends December CIK 0001652130 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

4
Insider
Date
Role
Action
Shares
Price
Amount
John M Leonard
2 Nov 2026
President and CEO
Sold on a plan
9,000
$11.99
$107.91K
John M Leonard
21 Aug 2026
President and CEO
Sold on a plan
2,785
$13.00
$36.21K
John M Leonard
20 Aug 2026
President and CEO
Sold on a plan
19,890
$12.60
$250.61K
Edward J Dulac III
2 Jul 2026
EVP, Chief Financial Officer
Sold on a plan
4,677
$18.00
$84.19K
Show all 21 transactions →

What was left out

Form 4 filings counted 30
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 3
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 660,244
History held since 9 May 2016